Emmerich I U
Dr. Ilka Ute Emmerich, VETIDATA, Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät der Universität Leipzig, An den Tierkliniken 39, 04103 Leipzig, E-Mail:
Tierarztl Prax Ausg K Kleintiere Heimtiere. 2013;41(4):237-43.
In 2012, three active pharmaceutical ingredients were released on the German market for small animals. These are the anti-thyroid Carbimazole (Vidalta®), the opium-derived analgesic Fentanyl (Fentadon®) and the antiepileptic Potassium Bromide (Libromide®). One substance was authorized for an additional species. The insecticide Flumethrin in combination with Imidacloprid is now also authorized for use in cats. Furthermore, this preparation includes an interesting new pharmaceutical form for dogs and cats and a new combination of active pharmaceutical ingredients for dogs. In addition, three active pharmaceutical ingredients with approval for use in human medicine, which are of potential interest to veterinary medicine, entered the market in 2012. These are the antidiabetic Dapagliflozin, the antiepileptic Perampanel and the Somatostatin-analog Pasireotide.
2012年，三种活性药物成分在德国小动物市场上市。它们分别是抗甲状腺药物卡比马唑（Vidalta®）、鸦片衍生的镇痛药芬太尼（Fentadon®）和抗癫痫药溴化钾（Libromide®）。有一种物质被批准用于额外的物种。氟氯氰菊酯与吡虫啉的组合现在也被批准用于猫。此外，这种制剂包括一种有趣的用于犬猫的新剂型和一种用于犬的活性药物成分新组合。另外，三种已批准用于人类医学、对兽医学有潜在意义的活性药物成分于2012年进入市场。它们分别是抗糖尿病药物达格列净、抗癫痫药物吡仑帕奈和生长抑素类似物帕西瑞肽。
